Skip to content
AwardedSpainGoodsFramework agreement€274,500

CONTR 2026 226993 CBAM-2 EXP 88/2025

Published
Published 17 July 2026

Overview

The Servicio Andaluz de Salud has awarded a framework agreement to Merck Sharp Dohme de España, S.A. for the supply of nonavalent human papillomavirus (HPV-9) vaccines for Andalusia's vaccination programme. The contract, valued at €285,480, establishes unit prices and conditions for successive supply of these vaccines to the region's public health system.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€274,500
Procedure
Direct
Contract type
Framework agreement
Published
17 July 2026
Classification (CPV)
Vaccines

Award outcome

Awarded value
€285,480
Award date
1 July 2026
Winner
  • MERCK SHARP DOHME DE ESPAÑA, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 July 2026

Contracting authority

  • Servicio Andaluz de Salud. Hospital Universitario Virgen de las Nieves

    Procuring entity

    Granada, Spain

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: CONTR 2026 226993 CBAM-2 EXP 88/2025 — won by MERCK SHARP DOHME DE ESPAÑA, S.A. — Skim